In CRC, AP4 directly inhibits the transcription of the miR-15a/16-1 host gene DLEU2, leading to the downregulation of DLEU2 and miR-15a/16-1 expression, thereby promoting EMT and tumor metastasis [28]. The gene discussed is DLEU2; the disease is neoplasm.